tiprankstipranks
Trending News
More News >
Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market

Design Therapeutics (DSGN) Income Statement

Compare
97 Followers

Design Therapeutics Income Statement

Last quarter (Q3 2025), Design Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Design Therapeutics's net income was $-17.00M. See Design Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -596.00K$ -537.00K$ -466.00K$ 0.00$ -5.00K
Operating Expenses
$ 61.79M$ 77.65M$ 67.13M$ 35.83M$ 8.55M
Depreciation and Amortization
$ 596.00K$ 537.00K$ 466.00K$ 129.00K$ 5.00K
EBITDA
$ -48.99M$ -66.33M$ -62.84M$ -35.70M$ -8.28M
Operating Income
$ -62.38M$ -78.19M$ -67.59M$ -35.83M$ -8.56M
Other Income/Expenses
$ 12.79M$ 11.33M$ 4.29M$ 298.00K$ 276.00K
Pretax Income
$ -49.59M$ -66.86M$ -63.31M$ -35.53M$ -8.28M
Net Income
$ -49.59M$ -66.86M$ -63.31M$ -35.53M$ -8.28M
Per Share Metrics
Basic EPS
$ -0.88$ -1.19$ -1.14$ -0.77$ -0.30
Diluted EPS
$ -0.88$ -1.19$ -1.14$ -0.77$ -0.30
Weighted Average Shares Outstanding
56.59M 55.98M 55.71M 45.94M 27.19M
Weighted Average Shares Outstanding (Diluted)
56.59M 55.98M 55.71M 45.94M 27.19M
Currency in USD

Design Therapeutics Earnings and Revenue History